Indications and uses
For relief of occasional constipation and irregularity. This product produces a bowel movement in 6 to 12 hours.
Sennosides
- Manufacturer
- NewVue LLC
- Effective date
- 2024-04-12
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 1
- Source
- full-release
- Hydrated at
- 2026-06-01 00:11:00
Label at a glance#
ProductSennosides
Active ingredientSENNOSIDES A AND B
Label structure8 sections
Dosage and administration
Take preferably at bedtime or as directed by a doctor. Adults and children over 12 years: 2 tablets once a day. Maximum of 4 tablets twice a day. Children 6 to under 12 years: 1 tablet once a day. Maximum of 2 tablets twice a day. Children 2 to under 6 years: 1/2 tablet once a day. Maximum of 1 tablet twice a day. Children under 2: consult a doctor
Label contents#
Full prescribing information#
Active Ingredient
Sennosides
Purpose
Laxative
Keep out of Reach of Children
In case of accidental overdose, contact a doctor or Poison Control Center immediately.
Uses
For relief of occasional constipation and irregularity.
This product produces a bowel movement in 6 to 12 hours.
Warnings
Do not use laxative products for more than one week unless directed by a doctor
Ask a doctor before use if you have stomach pains, nausea, vomiting, notice a sudden change in bowel habits that continues over a period of 2 weeks.
Stop use and ask a doctor ifrectal bleeding or failure to have a bowel movement occur after use of a laxative. These could be signs of a serious condition.
If Pregnant or breast-feedingask a health professional before use.
Directions
Take preferably at bedtime or as directed by a doctor.
Adults and children over 12 years: 2 tablets once a day. Maximum of 4 tablets twice a day.
Children 6 to under 12 years: 1 tablet once a day. Maximum of 2 tablets twice a day.
Children 2 to under 6 years: 1/2 tablet once a day. Maximum of 1 tablet twice a day.
Children under 2: consult a doctor
Inactive Ingredients
croscarmellose sodium, dibasic dicalcium phosphate, magnesium stearate, microcrystalline cellulose, and silicon dioxide.
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
DailyMed RxNorm Mappings#
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 83813-004-06 | Sennosides | 600 in 1 BOTTLE | TABLET | 600 | 1 |
DailyMed Dashboard NDC Coverage#
Products#
Every source-derived product name is available through these pages.
- Sennosides
- SILICON DIOXIDE
- CROSCARMELLOSE SODIUM
- STEARIC ACID
- MAGNESIUM STEARATE
- CELLULOSE, MICROCRYSTALLINE
- HYPROMELLOSES
- SENNOSIDES A AND B
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 83813-004 | 83813-004-06 |
Ingredients#
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| SILICON DIOXIDE | ETJ7Z6XBU4 | IACT |
| CROSCARMELLOSE SODIUM | M28OL1HH48 | IACT |
| STEARIC ACID | 4ELV7Z65AP | IACT |
| MAGNESIUM STEARATE | 70097M6I30 | IACT |
| CELLULOSE, MICROCRYSTALLINE | OP1R32D61U | IACT |
| HYPROMELLOSES | 3NXW29V3WO | IACT |
| SENNOSIDES A AND B | 1B5FPI42EN | ACTIB |
Source Document#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 15f244df-adc7-49ae-e063-6294a90a2d35 | 15f23c37-5b9f-d6be-e063-6394a90a0842 | 2024-04-12 | Warnings | 15f244df-adc7-49ae-e063-6294a90a2d35 15f23c37-5b9f-d6be-e063-6394a90a0842 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.